A retrospective study on chemotherapy-induced nausea and vomiting in highly/moderately emetogenic chemotherapy: incidence and prescribing practice

被引：0
|
作者：
Nurul Suhaida Badarudin
Noraida Mohamed Shah
Kamarun Neasa Begam Mohd Kassim
Fuad Ismail
Farida Islahudin
Nurul Ain Mohd Tahir
Suhana Yusak
机构：
[1] Universiti Kebangsaan Malaysia,Centre of Quality Management of Medicines, Faculty of Pharmacy
[2] Kuala Lumpur Campus,Department of Radiotherapy & Oncology
[3] Jalan Raja Muda Abdul Aziz,undefined
[4] National Cancer Institute,undefined
[5] Ministry of Health Malaysia,undefined
[6] Universiti Kebangsaan Malaysia Medical Centre,undefined
来源：
Supportive Care in Cancer | 2022年 / 30卷
关键词：
Chemotherapy-induced nausea vomiting; CINV; CINV incidence; Antiemetic; CINV prophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5339 / 5349
页数：10
相关论文
共 50 条
  • [21] Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
    Sachin, Hingmire
    Nirmal, Raut
    SOUTH ASIAN JOURNAL OF CANCER, 2015, 4 (01) : 7 - 10
  • [22] Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy
    Hu, Zhihuang
    Liang, Wenhua
    Yang, Yunpeng
    Keefe, Dorothy
    Ma, Yuxiang
    Zhao, Yuanyuan
    Xue, Cong
    Huang, Yan
    Zhao, Hongyun
    Chen, Likun
    Chan, Alexandre
    Zhang, Li
    MEDICINE, 2016, 95 (02)
  • [23] Incidence of chemotherapy-induced nausea and vomiting after highly and moderately emetogenic chemotherapy in the era of NK-1 receptor antagonists. Perception versus reality
    Majem, M.
    Moreno, E.
    Perez, J.
    Calvo, N.
    Feliu, A.
    Gich, I.
    Tibau, A.
    Mangues, M. A.
    Barnadas, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy
    Shih, Ya-Chen Tina
    Xu, Ying
    Elting, Linda S.
    CANCER, 2007, 110 (03) : 678 - 685
  • [25] A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
    Zelek, Laurent
    Debourdeau, Philippe
    Bourgeois, Hugues
    Wagner, Jean Philippe
    Brocard, Fabien
    Lefeuvre-Plesse, Claudia
    Chauffert, Bruno
    Leheurteur, Marianne
    Bachet, Jean-Baptiste
    Simon, Helene
    Mayeur, Didier
    Scotte, Florian
    ONCOLOGIST, 2021, 26 (10): : E1870 - E1879
  • [26] Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron
    Coluzzi, Flaminia
    Mattia, Consalvo
    FUTURE ONCOLOGY, 2016, 12 (16) : 1865 - 1876
  • [27] Safety of Palonosetron and Ondansetron in Preventing Chemotherapy-induced Nausea and Vomiting in Pediatric Patients Receiving Moderately-or Highly-Emetogenic Chemotherapy
    Kovacs, G.
    Wachtel, A. E.
    Basharova, E. V.
    Spinelli, T.
    Nicolas, P.
    Cipriani, S.
    Kabickova, E.
    DRUG SAFETY, 2014, 37 (10) : 843 - 843
  • [28] Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic (MEC) or highly emetogenic (HEC) chemotherapies in patients with lung cancer
    Rapoport, B.
    Boice, J. A.
    Brown, C.
    Street, J. C.
    Hardwick, J. S.
    Carides, A. D.
    Gralla, R. J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 519 - 520
  • [29] COST-EFFECTIVENESS OF PALONOSETRON FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ASSOCIATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY
    Rely, K.
    Pierre, K. A.
    Salinas, E. G.
    VALUE IN HEALTH, 2009, 12 (07) : A496 - A496
  • [30] Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy
    Moore, Susan
    Tumeh, John
    Wojtanowski, Steven
    Flowers, Christopher
    VALUE IN HEALTH, 2007, 10 (01) : 23 - 31
12345